Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Organoids and Spheroids Europe 2023

Isabella Bondesson's Biography

Isabella Bondesson, Application Scientist, Team Lead EMEA, CELLINK

Isabella Bondesson is a Field Application Scientist at CELLINK, the global leading bioprinting company. Isabella has a BioTech Engineering degree from Chalmers Institute of Technology, and she joined CELLINK in 2018 as part of the R&D team to develop novel methods in tissue model printing. During her time at CELLINK Isabella has acquired expertise in multiple areas of bioprinting and is today leading the EMEA Application team who work with consulting, educating, and supporting customer needs within various aspect of 3D Bioprinting. As the leading 3D bioprinting company, CELLINK is committed to providing the most advanced 3D bioprinting products, services and technologies needed to understand and master biology. CELLINK develops technologies that democratize 3D bioprinting – providing the leading researchers in the world the tools they need to create the future of health.

Isabella Bondesson Image

Bioprinting, Microfabrication and Biomaterials for Advanced Biological 3D Modeling

Tuesday, 20 June 2023 at 12:30

Add to Calendar ▼2023-06-20 12:30:002023-06-20 13:30:00Europe/LondonBioprinting, Microfabrication and Biomaterials for Advanced Biological 3D ModelingOrganoids and Spheroids Europe 2023 in Rotterdam, The NetherlandsRotterdam, The

Join us to discover how the latest innovations in 3D bioprinting and biomaterials are transforming the development of biomimetic models. In this seminar, we will explore the systems and materials that enable advanced 3D biofabrication techniques, ranging from vasculature networks, organ-on-a-chip devices and three-dimensional multi-stiffness tissue models with a keen focus on light-based printing technologies, and how they can be complemented with extrusion systems.

Learn about
  • Combining different 3D bioprinting technologies to create complex, multi-stiffness, and multi-material biomimetic models.
  • Recent advancements made in light based bioprinting including novel DLP printing mechanisms.
  • Advantages of working with defined, biological matrices of high quality in a wide array of cellular applications to access in-vivo like cellular response in 3D models.
  • Successful examples of sustainable, reproducible, and cost-efficient 3D models for rapid advancements within drug discovery, organ-on-a-chip models, and others.

Add to Calendar ▼2023-06-19 00:00:002023-06-20 00:00:00Europe/LondonOrganoids and Spheroids Europe 2023Organoids and Spheroids Europe 2023 in Rotterdam, The NetherlandsRotterdam, The